Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution
Brand names: Delflex
Category: Renal
FDA status: To Be Discontinued · Last FDA update: Sep 10, 2026 · First posted: Sep 10, 2026 · 1 manufacturers, 1 listed presentations
As of Sep 10, 2026, the FDA lists Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution as being discontinued. Of 1 manufacturer presentations, 1 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| DELFLEX, Solution, 18.4 mg/100 mL; 4.25 g/100 mL; 5.08 mg/100 mL; 538 mg/100 mL; 448 mg/100 mL (NDC 46163-212-95) NDC 46163-212-95 |
Fresenius Medical Care North America | Not specified | A business decision was made to discontinue manufacture of the drug. |
Related medications in shortage
Other Renal medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution (FDA data as of Sep 10, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Dextrose Monohydrate, Sodium Chloride, Sodium Lactate, Calcium Chloride, Magnesium Chloride Solution. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/dextrose-monohydrate-sodium-chloride-sodium-lactate-a22eae.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).